Bioengineering Center for Regeneration and Formation of Tissues (SC BioCRAFT)
组织再生与形成生物工程中心 (SC BioCRAFT)
基本信息
- 批准号:10670143
- 负责人:
- 金额:$ 114.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-07-01 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:Advisory CommitteesAffectAllograftingAreaAutologousAwardBasic ScienceBehaviorBiocompatible MaterialsBiomaterials ResearchBiomedical EngineeringBone TissueCapitalCardiovascular DiseasesCardiovascular systemCenters of Research ExcellenceClinicalCollaborationsCore FacilityDataDevelopmentDevelopmental BiologyDiabetes MellitusDisadvantagedDiseaseEconomicsEndowmentEngineeringEnsureEquipmentEvaluationExtramural ActivitiesFacultyFeesFosteringFundingFutureGoalsGrowth and Development functionHealthImageIn SituIndividualInfrastructureInstitutionKnowledgeLeadLeadershipLearningLifeMedicalMedicineMentorsMethodsMissionMorbidity - disease rateNational Institute of General Medical SciencesNatural regenerationNatureObesityOrgan failureOrganismOutcomePeer ReviewPhasePhysiologyPilot ProjectsPopulationPositioning AttributeProsthesisPublicationsRecoveryRegenerative MedicineResearchResearch InfrastructureResearch PersonnelResourcesScientistSouth CarolinaStrategic PlanningStrokeStructureTechnical ExpertiseTechnologyTestingTissue EngineeringTissuesTrainingTranslational ResearchTranslationsUnited States National Institutes of HealthUniversitiesXenograft procedurearmbiofabricationbioimagingcareerclinical applicationclinically relevantcostdesigndisabilityequipment acquisitionfaculty researchfortificationhuman diseaseimprovedinnovationinter-institutionalinterdisciplinary collaborationinterestmembermortalitymultidisciplinaryneuralnoveloutreachprogram costsprogramsrecruitstem cellssuccesssynergismtargeted treatmenttissue regenerationtissue repairtranslational goalvoucher
项目摘要
This COBRE Phase III application is aimed at sustaining the research infrastructure built during the first ten years
of NIGMS funding. Our COBRE “South Carolina Bioengineering Center for Regeneration and Formation of
Tissues” has become a nationally recognized, collaborative center with unique strengths in bioengineering
approaches to regenerative medicine. Three underlying themes define the Center's research: advance
biomaterial design and application; in situ tissue repair with targeted therapies; and applying the principles of
normal developmental biology to regenerative medicine or stem cell based tissue engineering. SC BioCRAFT
accomplishments towards these three translational goals include the recruitment of 10 new faculty, mentoring
and training of 23 COBRE target faculty, and the development of two research core facilities. Programmatic
outcomes include 26 independent NIH research awards, 62 research awards from other agencies to target
faculty, and >550 peer reviewed publications. South Carolina Centers of Economic Excellence: SmartState
awarded three endowed chairs in Regenerative Medicine and Advanced Tissue Biofabrication in partnerships
with Clemson and the University of South Carolina. SC BioCRAFT participated in the successful renewal of a
statewide INBRE award with a focus on bioengineering/regenerative medicine.
For this P30 application, the plan transitioning to independence of NIH/NIGMS support during the next five years
is to enhance and upgrade our core technologies, to increase their competitiveness, to attract greater usage
(and cost recovery), and to promote new research collaborations with our Center that can lead to submission of
competitive research applications and broaden our statewide outreach, especially to other IDeA centers. A seven
step, five-year strategic plan including implementing fee structures, pilot projects/voucher program, outreach
activities and programmatic development is proposed to sustain the SC BioCRAFT/COBRE center and its
scientific cores (Biomaterials Engineering and Testing and Translational Research Imaging). The founding
director of Clemson's SC BioCRAFT COBRE will lead the Administrative Core and will be assisted by two
outstanding scientists from Medical University of South Carolina who have themselves directed COBREs.
Together, these three leaders will act as the main operational arm of the Center. An External Advisory Committee
will provide ongoing assessment and evaluation of the Center's progress. Institutional commitments from the
Vice President for Research, ~2 million dollars, will help ensure programmatic growth development and long-
term sustainability of the Center.
COBRE 第三阶段应用旨在维持前十年建立的研究基础设施
我们的 COBRE“南卡罗来纳州再生和形成生物工程中心”
Tissues”已成为全国公认的在生物工程领域具有独特优势的协作中心
再生医学的方法定义了该中心的研究的三个基本主题: 进步
生物材料设计和应用;靶向治疗的原位组织修复和应用原理;
正常发育生物学到再生医学或基于干细胞的组织工程。
实现这三个转化目标的成就包括招聘 10 名新教师、提供指导
培训 23 名 COBRE 目标教员,并开发两个研究核心设施。
成果包括 26 项独立的 NIH 研究奖、62 项其他机构的研究奖
教师和超过 550 份同行评审的出版物。南卡罗来纳州经济卓越中心:SmartState
与伙伴关系授予再生医学和先进组织生物制造领域的三名特聘教授
与克莱姆森大学和南卡罗来纳大学一起成功更新了一个项目。
省级INBRE奖,重点关注生物工程/再生医学。
对于此 P30 申请,计划在未来五年内过渡到独立于 NIH/NIGMS 支持
是增强和升级我们的核心技术,提高其竞争力,吸引更多的使用
(和成本回收),并促进与我们中心的新研究合作,从而提交
竞争性研究应用并扩大我们的共同范围,特别是其他 IDeA A 七中心。
步骤,五年战略计划,包括实施费用结构、试点项目/优惠券计划、外展
建议开展活动和计划开发以维持 SC BioCRAFT/COBRE 中心及其
科学核心(生物材料工程和测试以及转化研究成像)。
克莱姆森 SC BioCRAFT COBRE 主任将领导行政核心,并由两名
来自南卡罗来纳医科大学的杰出科学家亲自指导 COBRE。
这三位领导人将共同充当该中心的主要运营部门。
将对中心的进展进行持续评估和评价。
研究副总裁约 200 万美元,将帮助确保计划性增长发展和长期
中心的长期可持续性。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
De Novo Self-Assembling Peptides Mediate the Conversion of Temozolomide and Delivery of a Model Drug into Glioblastoma Multiforme Cells.
从头自组装肽介导替莫唑胺的转化和模型药物向多形性胶质母细胞瘤细胞的递送。
- DOI:
- 发表时间:2022-09-02
- 期刊:
- 影响因子:4.7
- 作者:Pitz, Megan;Elpers, Margaret;Nukovic, Alexandra;Wilde, Sarah;Gregory, Arica Jordan;Alexander
- 通讯作者:Alexander
Factors Affecting Secondary and Supramolecular Structures of Self-Assembling Peptide Nanocarriers.
影响自组装肽纳米载体二级和超分子结构的因素。
- DOI:10.1002/mabi.202100347
- 发表时间:2021-11-20
- 期刊:
- 影响因子:4.6
- 作者:Megan E. Pitz;Ale;ra Nukovic;ra;Margaret A. Elpers;Angela A Ale;er;er
- 通讯作者:er
Assessing Anti-Adipogenic Effects of Mango Leaf Tea and Mangiferin within Cultured Adipocytes.
评估培养脂肪细胞内芒果叶茶和芒果苷的抗脂肪形成作用。
- DOI:
- 发表时间:2023-05-10
- 期刊:
- 影响因子:0
- 作者:Zarasvand, Sepideh Alasvand;Haley;Oladosu, Olanrewaju;Esobi, Ikechukwu;Powell, Rhonda Reigers;Bruce, Terri;Stamatikos, Alexis
- 通讯作者:Stamatikos, Alexis
The development of a nucleus pulposus-derived cartilage analog scaffold for chondral repair and regeneration.
开发用于软骨修复和再生的髓核来源的软骨模拟支架。
- DOI:10.1002/jbm.a.37639
- 发表时间:2023-11-14
- 期刊:
- 影响因子:0
- 作者:V. Thomas;Nathan Buchweitz;Jay John Baek;Yongren Wu;J. Mercuri
- 通讯作者:J. Mercuri
Targeted delivery of pentagalloyl glucose inhibits matrix metalloproteinase activity and preserves elastin in emphysematous lungs.
五没食子酰葡萄糖的靶向递送可抑制基质金属蛋白酶活性并保留肺气肿肺中的弹性蛋白。
- DOI:
- 发表时间:2021-09-18
- 期刊:
- 影响因子:5.8
- 作者:Parasaram, Vaideesh;Wang, Xiaoying;Krisanarungson, Pantrika;Vyavahare, Narendra
- 通讯作者:Vyavahare, Narendra
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Naren R Vyavahare其他文献
Naren R Vyavahare的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Naren R Vyavahare', 18)}}的其他基金
Pulmonary valved conduit xenograft with regeneration potential
具有再生潜力的肺动脉瓣导管异种移植物
- 批准号:
10086830 - 财政年份:2020
- 资助金额:
$ 114.29万 - 项目类别:
Bioengineering Center of Regeneration and Formation of Tissues (SC BioCRAFT)
组织再生与形成生物工程中心(SC BioCRAFT)
- 批准号:
10400406 - 财政年份:2019
- 资助金额:
$ 114.29万 - 项目类别:
Medial Arterial Calcification: Mechanisms and Therapy
内侧动脉钙化:机制和治疗
- 批准号:
10517640 - 财政年份:2019
- 资助金额:
$ 114.29万 - 项目类别:
Bioengineering Center for Regeneration and Formation of Tissues (SC BioCRAFT)
组织再生与形成生物工程中心 (SC BioCRAFT)
- 批准号:
10457960 - 财政年份:2019
- 资助金额:
$ 114.29万 - 项目类别:
Medial Arterial Calcification: Mechanisms and Therapy
内侧动脉钙化:机制和治疗
- 批准号:
10304908 - 财政年份:2019
- 资助金额:
$ 114.29万 - 项目类别:
相似国自然基金
基于lncRNA NONHSAT042241/hnRNP D/β-catenin轴探讨雷公藤衍生物(LLDT-8)对类风湿关节炎滑膜成纤维细胞功能影响及机制研究
- 批准号:82304988
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
针刺手法和参数对针刺效应启动的影响及其机制
- 批准号:82305416
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
二仙汤影响肾上腺皮质-髓质激素分泌及调控下丘脑温度感受器以缓解“天癸竭”潮热的研究
- 批准号:82374307
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
固定翼海空跨域航行器出水稳定性与流体动力载荷影响机制
- 批准号:52371327
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
经济制裁对跨国企业海外研发网络建构的影响:基于被制裁企业的视角
- 批准号:72302155
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Cell Therapy Program with Scale-up cGMP Manufacturing of Human Corneal Stromal Stem Cells
细胞治疗计划,扩大人类角膜基质干细胞的 cGMP 生产
- 批准号:
10720562 - 财政年份:2023
- 资助金额:
$ 114.29万 - 项目类别:
Epigenetic Regulation of Regulatory B Cell Cytokine Expression and Allograft Rejection
调节性 B 细胞细胞因子表达和同种异体移植排斥的表观遗传调控
- 批准号:
10349822 - 财政年份:2021
- 资助金额:
$ 114.29万 - 项目类别:
Epigenetic Regulation of Regulatory B Cell Cytokine Expression and Allograft Rejection
调节性 B 细胞细胞因子表达和同种异体移植排斥的表观遗传调控
- 批准号:
10542385 - 财政年份:2021
- 资助金额:
$ 114.29万 - 项目类别:
Bioengineering Center of Regeneration and Formation of Tissues (SC BioCRAFT)
组织再生与形成生物工程中心(SC BioCRAFT)
- 批准号:
10400406 - 财政年份:2019
- 资助金额:
$ 114.29万 - 项目类别:
Bioengineering Center for Regeneration and Formation of Tissues (SC BioCRAFT)
组织再生与形成生物工程中心 (SC BioCRAFT)
- 批准号:
10457960 - 财政年份:2019
- 资助金额:
$ 114.29万 - 项目类别: